| # | Drug | Count |
|---|---|---|
| 0 | ONABOTULINUMTOXINA | 751 |
| 1 | DUPILUMAB | 596 |
| 2 | ALIROCUMAB | 231 |
| 3 | HUMAN C1-ESTERASE INHIBITOR | 231 |
| 4 | SOMATROPIN | 226 |
| 5 | INCOBOTULINUMTOXINA | 216 |
| 6 | STIRIPENTOL | 201 |
| 7 | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER | 184 |
| 8 | CLOBAZAM | 170 |
| 9 | BOTULINUM TOXIN TYPE A | 150 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER | 184 | 0.3395 |
| 1 | SEPIAPTERIN | 55 | 0.2895 |
| 2 | STIRIPENTOL | 201 | 0.0880 |
| 3 | TESAMORELIN | 122 | 0.0721 |
| 4 | INCOBOTULINUMTOXINA | 216 | 0.0371 |
| 5 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 39 | 0.0349 |
| 6 | ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN) | 23 | 0.0210 |
| 7 | HUMAN C1-ESTERASE INHIBITOR | 231 | 0.0157 |
| 8 | PRABOTULINUM TOXIN TYPE A | 59 | 0.0156 |
| 9 | CEFUROXIME AXETIL | 52 | 0.0148 |
| # | Drug class | Count |
|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 1145 |
| 1 | Neuromuscular Blocker [EPC] | 1145 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 596 |
| 3 | PCSK9 Inhibitor [EPC] | 290 |
| 4 | Benzodiazepine [EPC] | 271 |
| 5 | Osmotic Laxative [EPC] | 210 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 198 |
| 7 | Corticosteroid [EPC] | 180 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 165 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 139 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 47 | 0.0683 |
| 1 | Cyclooxygenase Inhibitor [EPC] | 2 | 0.0244 |
| 2 | Melanocortin 4 Receptor Agonist [EPC] | 4 | 0.0140 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 60 | 0.0127 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 1145 | 0.0116 |
| 5 | PCSK9 Inhibitor [EPC] | 290 | 0.0113 |
| 6 | Carnitine Analog [EPC] | 36 | 0.0098 |
| 7 | Lymphocyte Activation Gene-3 Blocker [EPC] | 5 | 0.0097 |
| 8 | APOC-III-directed RNA Interaction [EPC] | 1 | 0.0096 |
| 9 | Leptin Analog [EPC] | 11 | 0.0087 |